Frailty Linked to Lower Bone Mineral Density in US Veterans with Rheumatoid Arthritis, Study Finds
USA: Results from a recent study presented at the American College of Rheumatology (ACR) Convergence 2024 in Washington, DC, show that frailty is linked to lower bone mineral density (BMD) in the total hip among a predominantly male cohort of veterans with rheumatoid arthritis (RA).
"We observed a significant association between frailty and total hip bone mineral density (THBMD) in a predominantly male cohort of US veterans with rheumatoid arthritis. Low BMD was common across the cohort. Measuring frailty could help identify individuals with RA at risk for low BMD and support osteoporosis screening in this high-risk group," the researchers reported.
Frailty, characterized by increased vulnerability to poor outcomes following physiological stressors, occurs at higher rates and younger ages in individuals with rheumatoid arthritis, particularly among women. While the relationship between frailty and low BMD and fractures has been well documented in predominantly female RA cohorts, there is limited data on this association in men. To fill this knowledge gap, Katherine Wysham from VA PUGET SOUND/UNIVERSITY OF WASHINGTON in Seattle, WA, and colleagues examined the relationship between frailty and bone mineral density in a predominantly male cohort of veterans with RA.
For this purpose, the researchers used data from the Veterans Affairs Rheumatoid Arthritis Frailty and Osteoporosis cohort, which included participants meeting the 2010 ACR RA criteria, aged ≥35. Frailty was assessed using the Fried Phenotype, categorizing individuals as robust, prefrail, or frail. BMD and body composition were measured with dual-energy x-ray absorptiometry. Low BMD was defined by T-score < -1.0 (total hip/femoral neck) for those >50, or Z-score < -2.0 for those ≤50. Univariable and multivariable regressions evaluated the association between frailty and total hip BMD, controlling for relevant factors, excluding osteoporosis medication use due to confounding.
The study revealed the following findings:
- 118 veterans were included in the study, with 73% being male and a mean age of 61.4±11.5 years.
- The cohort consisted of 70% White, 11% Black, 12% mixed-race, and 7% Hispanic/Latino participants.
- 8% were frail, 62% were prefrail, and 30% were robust.
- The frail group had the highest age, positive ACPA, HAQ score, pain, and CDAI.
- The frail group had the lowest prednisone dose, bDMARD use, %fat, and ALMI.
- The most common frailty components were exhaustion (48%), low hand grip strength (40%), and low physical activity (18%).
- Low BMD was present in 90% of the frail group, 48% of the prefrail group, and 46% of the robust group.
- Multivariable regression showed a significant negative association between frailty and total hip BMD (β=-0.147) compared to the robust group.
The researchers concluded that frailty assessment could help identify individuals with RA at risk for low BMD and inform osteoporosis screening in this high-risk population. They emphasized the need for future studies to determine if frailty can predict BMD loss, which would support its clinical application.
Reference:
Wysham K, Brubeck H, Riggles K, Bass R, Wahl E, Narla R, Singh N, orkaby a, Baker J, Katz P, Shoback D, Garcia J. Frailty Is Associated with Lower Bone Mineral Density in US Veterans with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/frailty-is-associated-with-lower-bone-mineral-density-in-us-veterans-with-rheumatoid-arthritis/. Accessed December 19, 2024.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.